Status:
ENROLLING_BY_INVITATION
Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy
Lead Sponsor:
Taipei City Hospital
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Breast cancer patients receiving adjuvant radiotherapy after surgery, particularly when the supraclavicular lymph nodes are included in the treatment area, frequently experience side effects of esopha...
Detailed Description
Breast cancer patients receiving adjuvant radiotherapy after surgery, particularly when the supraclavicular lymph nodes are included in the treatment area, frequently experience side effects of esopha...
Eligibility Criteria
Inclusion
- Patients over 18 years of age.
- Diagnosed with female breast cancer with metastatic lymphadenopathy undergoing adjuvant radiotherapy.
- Willing to participate in the alginate treatment trial.
Exclusion
- Concurrent chemotherapy during radiation therapy.
- Cognitive impairment or inability to respond to questionnaire content.
- Requirement for a low-sodium diet.
- Conditions such as heart failure, renal insufficiency
Key Trial Info
Start Date :
February 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06958445
Start Date
February 15 2024
End Date
December 1 2027
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei City Hospital, Renai Branch
Taipei, Taiwan, 10629